AXL and Cirrhosis: Importantly, the CD14+HLA-DR+AXL+ immune cell subset detailed here has to be distinguished from the recently identified immunosuppressive M-MDSCs in patients with cirrhosis and ACLF (20), which we observed expanding from Child A to C in our cohort.